Harrow Inc

Industry · 2 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Enrolling By Invitation	Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic So Diabetic Macular Edema (DME), Age-Related Macular Degeneration (AMD), Retinal Vein Occlusion	Phase 4	2026-03-31
Completed	The Effects of Low Viscosity Chloroprocaine Ophthalmic Gel 3% on the Bactericidal Action of Povidone-Iodine Antiseptic, Anesthesia, Local	Phase 4	2023-07-15